Global Genome Engineering Editing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Genome Engineering Editing market size will reach 10,938 Million USD in 2025 and is projected to reach 37,508 Million USD by 2032, with a CAGR of 19.25% (2025-2032). Notably, the China Genome Engineering Editing market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Genome engineering editing involves the precise modification of an organism＇s DNA using various molecular tools and techniques. This field has rapidly advanced in recent years with the development of technologies such as CRISPR-Cas9, zinc finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs). These tools allow researchers to make targeted changes to specific genes within an organism＇s genome, such as inserting, deleting, or modifying DNA sequences. Genome editing has numerous applications in both research and practical settings, including gene therapy for treating genetic disorders, creating genetically modified organisms (GMOs) for agriculture, and understanding the function of genes in biological systems. The precision and efficiency of genome editing technologies have revolutionized the study of genetics and hold immense potential for addressing various challenges in medicine, agriculture, and biotechnology. However, ethical considerations and potential unintended consequences must be carefully considered when using genome engineering editing techniques.
The major global suppliers of Genome Engineering Editing include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Genome Engineering Editing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Genome Engineering Editing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Genome Engineering Editing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Genome Engineering Editing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Genome Engineering Editing Include:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Genome Engineering Editing Product Segment Include:
Homologous Recombination
Meganuclease
Genome Engineering Editing Product Application Include:
Agriculture
Medical
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Genome Engineering Editing Industry PESTEL Analysis
Chapter 3: Global Genome Engineering Editing Industry Porter's Five Forces Analysis
Chapter 4: Global Genome Engineering Editing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Genome Engineering Editing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Genome Engineering Editing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Genome Engineering Editing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Genome Engineering Editing market size will reach 10,938 Million USD in 2025 and is projected to reach 37,508 Million USD by 2032, with a CAGR of 19.25% (2025-2032). Notably, the China Genome Engineering Editing market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Genome engineering editing involves the precise modification of an organism＇s DNA using various molecular tools and techniques. This field has rapidly advanced in recent years with the development of technologies such as CRISPR-Cas9, zinc finger nucleases (ZFNs), and transcription activator-like effector nucleases (TALENs). These tools allow researchers to make targeted changes to specific genes within an organism＇s genome, such as inserting, deleting, or modifying DNA sequences. Genome editing has numerous applications in both research and practical settings, including gene therapy for treating genetic disorders, creating genetically modified organisms (GMOs) for agriculture, and understanding the function of genes in biological systems. The precision and efficiency of genome editing technologies have revolutionized the study of genetics and hold immense potential for addressing various challenges in medicine, agriculture, and biotechnology. However, ethical considerations and potential unintended consequences must be carefully considered when using genome engineering editing techniques.
The major global suppliers of Genome Engineering Editing include Thermo Fisher Scientific, SIGMA ALDRICH, Dharmacon, Cellectics, CRISPR Therapeutics, AstraZeneca, Bio Rad, Allele Biotech, Recombinetics, Lonza, GE Healthcare, Editas Medicine, Agilent Technologies, QIAGEN NV, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Genome Engineering Editing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Genome Engineering Editing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Genome Engineering Editing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Genome Engineering Editing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Genome Engineering Editing Include:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Genome Engineering Editing Product Segment Include:
Homologous Recombination
Meganuclease
Genome Engineering Editing Product Application Include:
Agriculture
Medical
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Genome Engineering Editing Industry PESTEL Analysis
Chapter 3: Global Genome Engineering Editing Industry Porter's Five Forces Analysis
Chapter 4: Global Genome Engineering Editing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Genome Engineering Editing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Genome Engineering Editing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Genome Engineering Editing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Genome Engineering Editing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Genome Engineering Editing Product by Type
- 1.2.1 Homologous Recombination
- 1.2.2 Meganuclease
- 1.3 Genome Engineering Editing Product by Application
- 1.3.1 Agriculture
- 1.3.2 Medical
- 1.3.3 Others
- 1.4 Global Genome Engineering Editing Market Size Analysis (2020-2032)
- 1.5 Genome Engineering Editing Market Development Status and Trends
- 1.5.1 Genome Engineering Editing Industry Development Status Analysis
- 1.5.2 Genome Engineering Editing Industry Development Trends Analysis
- 2 Genome Engineering Editing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Genome Engineering Editing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Genome Engineering Editing Market Analysis by Country
- 4.1 Global Genome Engineering Editing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Genome Engineering Editing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Genome Engineering Editing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Genome Engineering Editing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Genome Engineering Editing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Genome Engineering Editing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Genome Engineering Editing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Genome Engineering Editing Market Analysis by Type
- 6.1 Global Genome Engineering Editing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Genome Engineering Editing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Scientific Genome Engineering Editing Product Portfolio
- 7.1.3 Thermo Fisher Scientific Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 SIGMA ALDRICH
- 7.2.1 SIGMA ALDRICH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 SIGMA ALDRICH Genome Engineering Editing Product Portfolio
- 7.2.3 SIGMA ALDRICH Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Dharmacon
- 7.3.1 Dharmacon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Dharmacon Genome Engineering Editing Product Portfolio
- 7.3.3 Dharmacon Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Cellectics
- 7.4.1 Cellectics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Cellectics Genome Engineering Editing Product Portfolio
- 7.4.3 Cellectics Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 CRISPR Therapeutics
- 7.5.1 CRISPR Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 CRISPR Therapeutics Genome Engineering Editing Product Portfolio
- 7.5.3 CRISPR Therapeutics Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 AstraZeneca
- 7.6.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 AstraZeneca Genome Engineering Editing Product Portfolio
- 7.6.3 AstraZeneca Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Bio Rad
- 7.7.1 Bio Rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bio Rad Genome Engineering Editing Product Portfolio
- 7.7.3 Bio Rad Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Allele Biotech
- 7.8.1 Allele Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Allele Biotech Genome Engineering Editing Product Portfolio
- 7.8.3 Allele Biotech Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Recombinetics
- 7.9.1 Recombinetics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Recombinetics Genome Engineering Editing Product Portfolio
- 7.9.3 Recombinetics Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Lonza
- 7.10.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Lonza Genome Engineering Editing Product Portfolio
- 7.10.3 Lonza Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 GE Healthcare
- 7.11.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 GE Healthcare Genome Engineering Editing Product Portfolio
- 7.11.3 GE Healthcare Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Editas Medicine
- 7.12.1 Editas Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Editas Medicine Genome Engineering Editing Product Portfolio
- 7.12.3 Editas Medicine Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Agilent Technologies
- 7.13.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Agilent Technologies Genome Engineering Editing Product Portfolio
- 7.13.3 Agilent Technologies Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 QIAGEN NV
- 7.14.1 QIAGEN NV Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 QIAGEN NV Genome Engineering Editing Product Portfolio
- 7.14.3 QIAGEN NV Genome Engineering Editing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Genome Engineering Editing Industry Chain Analysis
- 8.2 Genome Engineering Editing Product Downstream Application Analysis
- 8.2.1 Global Genome Engineering Editing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Genome Engineering Editing Revenue and Forecast by Application (2020-2032)
- 8.3 Genome Engineering Editing Typical Downstream Customers
- 8.4 Genome Engineering Editing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
